4
Changes in Ownership
Lipocine Inc. Filed Acc 0001638599-20-000948
Chief Financial Officer sold 17,250 shares at $1.57 ($27,024)
- Chief Financial Officer acquired 128,254 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BROWN MORGAN R Chief Financial Officer | 2020-12-04 | Option exercise | +57,500 | 121,312 | D | ||
| BROWN MORGAN R Chief Financial Officer | 2020-12-04 | Sale | −17,250 | $1.57 | $27,024 | 104,062 | D |
| BROWN MORGAN R Chief Financial Officer | 2020-12-05 | Option exercise | +70,754 | 174,816 | D | ||
| Derivatives | |||||||
| BROWN MORGAN R Chief Financial Officer | 2020-12-04 | Option exercise · Restricted Stock Unit | −57,500 | 57,500 | D | ||
| BROWN MORGAN R Chief Financial Officer | 2020-12-05 | Option exercise · Restricted Stock Unit | −70,754 | 70,754 | D | ||
| Open-market sales · 17,250 sh · avg $1.57 · $27,024 | |||||||
Loading xslF345X03/doc4_6947.xml…